|
NCOA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.08509995328166E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.01560004850398E-09 |
| Normal-vs-Stage2 |
3.784900E-03 |
| Normal-vs-Stage3 |
4.757500E-03 |
| Normal-vs-Stage4 |
9.344400E-03 |
| Stage1-vs-Stage2 |
4.116600E-01 |
| Stage1-vs-Stage3 |
2.483600E-01 |
| Stage1-vs-Stage4 |
8.807200E-01 |
| Stage2-vs-Stage3 |
8.731600E-01 |
| Stage2-vs-Stage4 |
5.255000E-01 |
| Stage3-vs-Stage4 |
4.672000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.49479994838009E-09 |
| Normal-vs-AfricanAmerican |
2.19969999992742E-08 |
| Normal-vs-Asian |
1.237550E-04 |
| Caucasian-vs-AfricanAmerican |
3.486600E-01 |
| Caucasian-vs-Asian |
4.596400E-01 |
| AfricanAmerican-vs-Asian |
5.655400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.69929667296287E-11 |
| Normal-vs-Female |
7.616400E-03 |
| Male-vs-Female |
8.751100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.77590000000661E-05 |
| Normal-vs-Extreme_Weight |
1.36369804337733E-11 |
| Normal-vs-Obese |
4.18790000000779E-06 |
| Normal-vs-Extreme_Obese |
6.28059999999708E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.883590E-01 |
| Normal_Weight-vs-Obese |
5.770200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.199800E-01 |
| Extreme_Weight-vs-Obese |
1.220010E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.427000E-01 |
| Obese-vs-Extreme_Obese |
4.047800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.678760E-03 |
| Normal-vs-Age(41-60Yrs) |
1.75279999958811E-07 |
| Normal-vs-Age(61-80Yrs) |
6.31300012265967E-10 |
| Normal-vs-Age(81-100Yrs) |
1.07630000001357E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.471200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.970800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.909380E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.699750E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.033600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.007400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.63740140837854E-11 |
| Normal-VS-Type2 PRCC |
7.95420000000435E-05 |
| Normal-VS-KIRP CIMP |
1.782800E-01 |
| Normal-VS-Unclassified PRCC |
1.472340E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.753900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.281900E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.150400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.655200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.127400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.773000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.22320000981591E-09 |
| Normal-vs-N1 |
2.075500E-02 |
| Normal-vs-N2 |
8.408100E-02 |
| N0-vs-N1 |
1.224450E-01 |
| N0-vs-N2 |
3.349200E-01 |
| N1-vs-N2 |
9.949800E-01 |
|
|
